PacBio Files Q1 2025 10-Q
Ticker: PACB · Form: 10-Q · Filed: May 12, 2025 · CIK: 1299130
Sentiment: neutral
Topics: 10-Q, financials, reporting
Related Tickers: PACB
TL;DR
**PACB Q1 2025 10-Q FILED: Financials and operations update for the period ending March 31, 2025.**
AI Summary
Pacific Biosciences of California, Inc. (PACB) filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the laboratory analytical instruments sector.
Why It Matters
This filing provides investors with the latest financial health and operational performance of Pacific Biosciences, a key player in genetic sequencing technology.
Risk Assessment
Risk Level: medium — The company operates in a highly competitive and rapidly evolving technological sector, which inherently carries significant market and innovation risks.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for which the report is filed.)
- 20250512 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — Filer
- Menlo Park, CA (location) — Business and Mail Address
- 001-34899 (other) — SEC File Number
FAQ
What is the primary business of Pacific Biosciences of California, Inc.?
Pacific Biosciences of California, Inc. is involved in the Laboratory Analytical Instruments sector, SIC code 3826.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 12, 2025.
What are the company's former names?
The company was formerly known as Pacific Biosciences of California Inc. and prior to that, Nanofluidics Inc.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).